A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation
Jessica Ezzell Hunter(Kaiser Permanente Center for Health Research), Katrina A.B. Goddard(National Institutes of Health), Sheri D. Schully(National Institutes of Health), Marc S. Williams(Geisinger Health System), Margaret Piper(Kaiser Permanente Center for Health Research), Laura V. Milko(University of North Carolina at Chapel Hill), Erin M. Ramos, Elizabeth M. Webber(Kaiser Permanente Center for Health Research), Annie Niehaus(National Institutes of Health), Anne Slavotinek(Cincinnati Children's Hospital Medical Center), Jonathan S. Berg(University of North Carolina at Chapel Hill), Natasha T. Strande(University of North Carolina at Chapel Hill), Kristy Lee(University of North Carolina at Chapel Hill), Julianne O’Daniel(University of North Carolina at Chapel Hill), Stephanie A. Irving(Kaiser Permanente Center for Health Research), James P. Evans(University of North Carolina at Chapel Hill), Adam H. Buchanan(Geisinger Health System), Christa Lese Martin(Autism & Developmental Medicine Institute), Meredith Weaver(American College of Medical Genetics), Leslie G. Biesecker(National Institutes of Health), Kristin R. Muessig(Kaiser Permanente Center for Health Research), Nara Sobreira(Johns Hopkins University), Brian C. Jensen(University of North Carolina at Chapel Hill)
Cited by 152
Related Papers
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
|Neuron|2015|1.5k
CHARGE Association: An Update and Review for the Primary Pediatrician
|Clinical Pediatrics|1998|451
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
|Nature Genetics|2016|393